Results for
"[search-keyword]"
Sponsor content
811 result(s) found, displaying 201 to 210
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., 29/01/2023
-
Prescription medicine registrationActive ingredients: Rivaroxaban.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACY HEALTH PARACETAMOL 500 mg tablet blister pack (formulation 5).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PRICELINE PARACETAMOL 500 mg tablet blister pack (formulation 3).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TERRYWHITE CHEMMART PARACETAMOL 500 mg tablet blister pack (formulation 3).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cipla Bisoprolol 5 bisoprolol fumarate 5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cipla Bisoprolol 10 bisoprolol fumarate 10 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cipla Bisoprolol 2.5 bisoprolol fumarate 2.5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BEVACIPTIN bevacizumab 400 mg/16 mL concentrated solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BEVACIP bevacizumab 100 mg/4 mL concentrated solution for infusion vial.